DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Agnelli G. et al.
ODIXa-DVT Study Investigators. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59–7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59–7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
Circulation 2007;
116: 180-187.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.